---
title: "MGL New Materials: Yindi and others reduced their holdings by 2.33% from June to September"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/258509395.md"
description: "MGL New Materials announced that Beijing Yindi Investment Co., Ltd. and its concerted parties, Lianyungang Honglai Enterprise Management Partnership and Yancheng New Lithium Technology Co., Ltd., reduced their holdings by a total of 10.701 million shares through centralized bidding and block trading from June 23, 2025, to September 22, 2025, with a reduction ratio of 2.33%; Lu Chunquan and his concerted parties, Qiongcheng Purun Lifan Investment Partnership, reduced their holdings by a total of 5.6641 million shares during the same period, with a reduction ratio of 1.23%. After the reduction, the two parties hold 7.80% and 4.91% of the shares, respectively"
datetime: "2025-09-23T11:17:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258509395.md)
  - [en](https://longbridge.com/en/news/258509395.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258509395.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/258509395.md) | [English](https://longbridge.com/en/news/258509395.md)


# MGL New Materials: Yindi and others reduced their holdings by 2.33% from June to September

MGL New Materials announced that Beijing Yindi Investment Co., Ltd. and its concerted parties, Lianyungang Honglai Enterprise Management Partnership and Yancheng New Lithium Technology Co., Ltd., will reduce their holdings by a total of 10.701 million shares through centralized bidding and block trading from June 23, 2025, to September 22, 2025, representing a reduction ratio of 2.33%. Lu Chunquan and his concerted parties, Qiongcheng Purun Lifan Investment Partnership, will reduce their holdings by a total of 5.6641 million shares during the same period, representing a reduction ratio of 1.23%. After the reduction, the two parties will hold 7.80% and 4.91% of the shares, respectively

### 相關股票

- [MGL New Materials (301487.CN)](https://longbridge.com/zh-HK/quote/301487.CN.md)

## 相關資訊與研究

- [08:54 ETNew Research Claims to Show Bioavailability of Oral Liposomal Glutathione. But does it really?](https://longbridge.com/zh-HK/news/281371900.md)
- [Cosigo Resources Extends Private Placement to Advance Gold Exploration Assets](https://longbridge.com/zh-HK/news/281460385.md)
- [Ganfeng Lithium Turns to 2025 Profit](https://longbridge.com/zh-HK/news/281121946.md)
- [California's top lawyer explains why he hasn't sued Kalshi like Nevada and Arizona](https://longbridge.com/zh-HK/news/281499429.md)
- [Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst⢠(bumetanide nasal spray)](https://longbridge.com/zh-HK/news/281570860.md)